What Does It Mean To Be Refractory To Revlimid®

What does it mean to be refractory to Revlimid®? What other treatment options are available?

International Myeloma Foundation

Managing lenalidomide-refractory myeloma patients

VJHemOnc – Video Journal of Hematology & HemOnc

Lenalidomide-Refractory Multiple Myeloma

What impact do Revlimid® (lenalidomide) and Pomalyst® (pomalidomide) have on the bone marrow?

International Myeloma Foundation

Dr. Goy Discusses the Approval of Revlimid for Patients with Relapsed or Refractory MCL

Targeted Oncology

What Are the Treatment Options for Patients With Lenalidomide-Refractory Myeloma?

Blood Cancers Today

All About Revlimid (lenalidomide) #myeloma

HealthTree University for Multiple Myeloma

OPTIMISMM: investigating an alternative therapy for lenalidomide-refractory patients

VJHemOnc – Video Journal of Hematology & HemOnc

What Are Relapsed and Refractory Myeloma?

Patient Empowerment Network

What is relapsed and refractory myeloma? | Experts Explain #myeloma

HealthTree University for Multiple Myeloma

Treatment options for patients with multiple myeloma refractory to lenalidomide

VJHemOnc – Video Journal of Hematology & HemOnc

Assessing treatment options for multiple myeloma and managing lenalidomide-refractory disease

Approaching the treatment of lenalidomide refractory patients with multiple myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

When and How You Become Refractory to a Drug and How to Find the Best Next Treatment

HealthTree Foundation for Multiple Myeloma

What is Revlimid?

Real-world evidence of the use of carfilzomib to refractory to lenalidomide patients

Noa Biran, MD, on combination carfilzomib & daratumumab in revlimid-refractory multiple myeloma

Is a generic version of Revlimid available?

International Myeloma Foundation

Dr. Siegel on Pomalidomide in Lenalidomide-Refractory Patients With Myeloma

Approaching lenalidomide-refractory multiple myeloma: unmet needs and ongoing trials

VJHemOnc – Video Journal of Hematology & HemOnc